$HD

Home Depot (NYSE:HD) Beats Q2 CY2026 Sales Expectations

Home Depot (NYSE: HD) reported Q2 CY2026 sales of $47.86 billion, up 5.7% YoY, exceeding estimates. Non-GAAP EPS was $4.92, 4% above consensus. Revenue grew 3% CAGR over 3 years. Same-store sales rose 1.7% YoY. Analysts expect 3.2% revenue growth over the next 12 months.

Original reporting
Published Aug 18, 2026, 9:15 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 18, 2026, 9:28 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Home Depot (NYSE:HD) Beats Q2 CY2026 Sales Expectations — source image
Decision brief

The 30-second read

$HDBullishMed
01

Why it matters

Traders can use the beat versus consensus and the modest same-store acceleration to reassess near-term earnings power, while monitoring whether flat store growth constrains future top-line momentum.

02

Market read

A concrete earnings-style datapoint (revenue and EPS beat) with limited forward detail, likely driving short-term sentiment more than changing long-term fundamentals.

03

What to watch

The article does not quantify gross margin details or guidance beyond a generic 12-month revenue growth expectation, limiting conviction on forward estimates.

Relevance 7/10Novelty 6/10Timing: after-hours/next-session reaction to Q2 CY2026 results beat

Background

The piece frames Home Depot’s Q2 CY2026 performance versus Wall Street expectations, including revenue, non-GAAP EPS, store count, and same-store sales.

Company-level read

Ticker impact

$HDBullishMedium confidence
Context

Home Depot reported Q2 CY2026 revenue up 5.7% to $47.86B and non-GAAP EPS $4.92, beating consensus by 1.2% on sales.

Expected impact

Near-term bias modestly positive, with upside capped unless management shows stronger organic growth or margin follow-through.

Evidence & confidence

The article provides concrete beat figures and notes same-store sales acceleration, but also highlights flat store footprint and only modest organic growth.

Market effects

Supports the view that home improvement retail demand is holding up, though organic growth remains only modest.

No specific regional demand signals provided.

No direct global macro or supply-chain shocks mentioned.

Counterpoint

The beat may be more about margins and accounting (non-GAAP) than broad-based demand, given same-store sales were only 1.7% and store count is flat.

Key entities

  • Home Depot

    Home improvement retailer reporting Q2 CY2026 revenue and non-GAAP EPS results, plus same-store sales and store count.

Related articles

$HDMed

Home Depot Just Flashed a Housing Market Warning

Home Depot (HD) reported Q2 revenue of $47.86B, beating estimates, with adjusted earnings of $4.92 per share. Comparable sales rose 1.7% globally, driven by smaller projects. The company maintained its full-year outlook but noted high borrowing costs are restraining big-ticket demand. Shares rose 2% in premarket trading.

$HDMed

Is Home Depot a Buy After Its Latest Report?

Home Depot reported Q2 revenue of $47.86B, beating estimates, with same-store sales up 1.7% globally. EPS rose to $4.92, topping consensus. The company reaffirmed full-year guidance, expecting flat to 2% comp sales growth and 2.5%-4.5% revenue growth. Digital sales grew 11%, marking five straight quarters of double-digit gains.

$HDMedAI 8/10

Home Depot beats quarterly estimates on smaller project demand

Home Depot reported Q2 sales of $47.9B, up 5.7% YoY, and adjusted earnings of $4.92 per share, beating estimates. Comparable sales rose 1.7%, driven by smaller projects. Jefferies noted strong average ticket size growth. The company affirmed its full-year guidance, expecting 2.5% to 4.5% sales growth. Shares rose 0.7% on the news.

$METAMed

Stocks making the biggest moves midday: Meta, Amylyx, Baidu, Klarna, Coherent, Sandisk & more

Amylyx Pharmaceuticals shares rose 53% after its avexitide treatment met trial endpoints. Meta Platforms fell 3% amid a lawsuit. Carvana dropped 3% after director stock sales. UGI Corporation surged 12% on a $9B KKR bid report. AI-related stocks declined. Klarna fell 21% on weak guidance. Baidu dropped 12% on earnings miss. Home Depot rose slightly on earnings beat. Fabrinet fell 20% on margin concerns. Memory stocks declined. Duolingo rose 7% on an upgrade.